Bath Savings Trust’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $377K | Buy |
15,646
+730
| +5% | +$19.1K | 0.04% | 142 |
|
|
2026
Q1 | $419K | Sell |
14,916
-986
| -6% | -$26.3K | 0.04% | 133 |
|
|
2025
Q4 | $396K | Buy |
15,902
+1,336
| +9% | +$33.7K | 0.04% | 137 |
|
|
2025
Q3 | $371K | Sell |
14,566
-520
| -3% | -$12.8K | 0.04% | 135 |
|
|
2025
Q2 | $366K | Sell |
15,086
-300
| -2% | -$7K | 0.04% | 133 |
|
|
2025
Q1 | $390K | Sell |
15,386
-27,842
| -64% | -$729K | 0.04% | 126 |
|
|
2024
Q4 | $1.15M | Sell |
43,228
-160
| -0.4% | -$4.34K | 0.12% | 92 |
|
|
2024
Q3 | $1.26M | Sell |
43,388
-1,144
| -3% | -$33.4K | 0.12% | 88 |
|
|
2024
Q2 | $1.25M | Sell |
44,532
-1,288
| -3% | -$35.5K | 0.13% | 88 |
|
|
2024
Q1 | $1.27M | Buy |
45,820
+4,205
| +10% | +$117K | 0.14% | 90 |
|
|
2023
Q4 | $1.2M | Sell |
41,615
-852
| -2% | -$25.8K | 0.13% | 91 |
|
|
2023
Q3 | $1.41M | Sell |
42,467
-534
| -1% | -$18.9K | 0.17% | 83 |
|
|
2023
Q2 | $1.58M | Sell |
43,001
-731
| -2% | -$28.5K | 0.18% | 85 |
|
|
2023
Q1 | $1.78M | Sell |
43,732
-1,565
| -3% | -$67.6K | 0.22% | 73 |
|
|
2022
Q4 | $2.32M | Buy |
45,297
+78
| +0.2% | +$3.74K | 0.3% | 67 |
|
|
2022
Q3 | $1.98M | Buy |
45,219
+118
| +0.3% | +$5.73K | 0.28% | 69 |
|
|
2022
Q2 | $2.37M | Sell |
45,101
-113
| -0.2% | -$5.76K | 0.31% | 67 |
|
|
2022
Q1 | $2.34M | Buy |
45,214
+5,530
| +14% | +$287K | 0.27% | 69 |
|
|
2021
Q4 | $2.34M | Buy |
39,684
+200
| +0.5% | +$9.91K | 0.24% | 69 |
|
|
2021
Q3 | $1.7M | Sell |
39,484
-362
| -0.9% | -$16K | 0.2% | 74 |
|
|
2021
Q2 | $1.56M | Sell |
39,846
-994
| -2% | -$38.7K | 0.18% | 78 |
|
|
2021
Q1 | $1.48M | Buy |
40,840
+18,658
| +84% | +$662K | 0.19% | 78 |
|
|
2020
Q4 | $817K | Buy |
22,182
+1,744
| +9% | +$64K | 0.11% | 87 |
|
|
2020
Q3 | $712K | Buy |
20,438
+874
| +4% | +$30.6K | 0.12% | 82 |
|
|
2020
Q2 | $607K | Sell |
19,564
-408
| -2% | -$13.9K | 0.11% | 82 |
|
|
2020
Q1 | $618K | Hold |
19,972
| – | – | 0.13% | 75 |
|
|
2019
Q4 | $743K | Buy |
19,972
+2,883
| +17% | +$103K | 0.13% | 77 |
|
|
2019
Q3 | $583K | Sell |
17,089
-1,058
| -6% | -$38.5K | 0.11% | 81 |
|
|
2019
Q2 | $746K | Buy |
18,147
+595
| +3% | +$23.6K | 0.15% | 72 |
|
|
2019
Q1 | $708K | Sell |
17,552
-316
| -2% | -$12.7K | 0.15% | 72 |
|
|
2018
Q4 | $740K | Buy |
17,868
+472
| +3% | +$19.6K | 0.18% | 72 |
|
|
2018
Q3 | $727K | Sell |
17,396
-106
| -0.6% | -$4.08K | 0.16% | 76 |
|
|
2018
Q2 | $603K | Sell |
17,502
-2,017
| -10% | -$68.9K | 0.14% | 86 |
|
|
2018
Q1 | $657K | Sell |
19,519
-393
| -2% | -$13.5K | 0.16% | 82 |
|
|
2017
Q4 | $684K | Buy |
19,912
+780
| +4% | +$26.6K | 0.17% | 83 |
|
|
2017
Q3 | $648K | Sell |
19,132
-163
| -0.8% | -$5.24K | 0.17% | 84 |
|
|
2017
Q2 | $615K | Buy |
19,295
+479
| +3% | +$15.1K | 0.17% | 83 |
|
|
2017
Q1 | $611K | Sell |
18,816
-347
| -2% | -$10.9K | 0.18% | 83 |
|
|
2016
Q4 | $590K | Buy |
19,163
+106
| +0.6% | +$3.24K | 0.18% | 86 |
|
|
2016
Q3 | $613K | Buy |
19,057
+1,111
| +6% | +$37.1K | 0.19% | 84 |
|
|
2016
Q2 | $599K | Sell |
17,946
-3,094
| -15% | -$98.7K | 0.19% | 78 |
|
|
2016
Q1 | $592K | Buy |
21,040
+1,382
| +7% | +$39.5K | 0.19% | 80 |
|
|
2015
Q4 | $602K | Buy |
19,658
+258
| +1% | +$8.12K | 0.2% | 82 |
|
|
2015
Q3 | $578K | Sell |
19,400
-634
| -3% | -$20.3K | 0.2% | 80 |
|
|
2015
Q2 | $637K | Sell |
20,034
-3,506
| -15% | -$114K | 0.22% | 76 |
|
|
2015
Q1 | $777K | Sell |
23,540
-4,216
| -15% | -$134K | 0.26% | 73 |
|
|
2014
Q4 | $820K | Buy |
27,756
+422
| +2% | +$12.1K | 0.28% | 71 |
|
|
2014
Q3 | $767K | Hold |
27,334
| – | – | 0.29% | 67 |
|
|
2014
Q2 | $769K | Buy |
27,334
+2,002
| +8% | +$57.1K | 0.29% | 66 |
|
|
2014
Q1 | $772K | Buy |
25,332
+633
| +3% | +$18.9K | 0.31% | 65 |
|
|
2013
Q4 | $718K | Buy |
24,699
+2,383
| +11% | +$69.4K | 0.29% | 66 |
|
|
2013
Q3 | $608K | Buy |
22,316
+7,171
| +47% | +$195K | 0.27% | 70 |
|
|
2013
Q2 | $403K | Buy |
+15,145
| New | +$418K | 0.19% | 80 |
|
Other funds holding PFE
CWP
FWIA
ORIO
CNB
Bath Savings Trust's PFE Position: Q2 2026 in Review
Bath Savings Trust increased its Pfizer (PFE) stake by 4.9% in Q2 2026, buying an estimated $19.1K and bringing the position to 15,646 shares worth $377K. The position accounts for 0.04% of the portfolio, ranked #142.
Bath Savings Trust first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.37M in Q2 2022. 676 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Bath Savings Trust held 15,646 shares of Pfizer worth $377K as of Q2 2026.
- Bath Savings Trust bought 730 Pfizer shares in Q2 2026, an estimated $19.1K.
- Pfizer made up 0.04% of Bath Savings Trust's portfolio in Q2 2026, its #142 holding.
- Bath Savings Trust first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Bath Savings Trust's Pfizer position peaked at $2.37M in Q2 2022.
- 676 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Bath Savings Trust's 13F filing for Q2 2026, filed 9 Jul 2026.